These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 38885755)

  • 1. Comparative analysis of lysophospholipid metabolism profiles and clinical characteristics in patients with high vs. low C-reactive protein levels in acute exacerbations of chronic obstructive pulmonary disease.
    Zhou Q; Chang C; Wang Y; Gai X; Chen Y; Gao X; Liang Y; Sun Y
    Clin Chim Acta; 2024 Jul; 561():119816. PubMed ID: 38885755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in the lipid metabolism profile and clinical characteristics between eosinophilic and non-eosinophilic acute exacerbation of chronic obstructive pulmonary disease.
    Wang Y; Chang C; Tian S; Wang J; Gai X; Zhou Q; Chen Y; Gao X; Sun Y; Liang Y
    Front Mol Biosci; 2023; 10():1204985. PubMed ID: 37503537
    [No Abstract]   [Full Text] [Related]  

  • 3. C-reactive protein point-of-care testing for safely reducing antibiotics for acute exacerbations of chronic obstructive pulmonary disease: the PACE RCT.
    Francis NA; Gillespie D; White P; Bates J; Lowe R; Sewell B; Phillips R; Stanton H; Kirby N; Wootton M; Thomas-Jones E; Hood K; Llor C; Cals J; Melbye H; Naik G; Gal M; Fitzsimmons D; Alam MF; Riga E; Cochrane A; Butler CC
    Health Technol Assess; 2020 Mar; 24(15):1-108. PubMed ID: 32202490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-reactive protein levels in patients with chronic obstructive pulmonary disease: role of infection.
    Bircan A; Gokirmak M; Kilic O; Ozturk O; Akkaya A
    Med Princ Pract; 2008; 17(3):202-8. PubMed ID: 18408388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphingosine-1-phosphate and CRP as potential combination biomarkers in discrimination of COPD with community-acquired pneumonia and acute exacerbation of COPD.
    Hsu CW; Suk CW; Hsu YP; Chang JH; Liu CT; Huang SK; Hsu SC
    Respir Res; 2022 Mar; 23(1):63. PubMed ID: 35307030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum amyloid a is a biomarker of acute exacerbations of chronic obstructive pulmonary disease.
    Bozinovski S; Hutchinson A; Thompson M; Macgregor L; Black J; Giannakis E; Karlsson AS; Silvestrini R; Smallwood D; Vlahos R; Irving LB; Anderson GP
    Am J Respir Crit Care Med; 2008 Feb; 177(3):269-78. PubMed ID: 18006888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploration of biomarkers for efficacy evaluation of traditional Chinese medicine syndromes of acute exacerbation of chronic obstructive pulmonary disease based on metabolomics.
    Hailong Z; Yimei S; Yan D; Xinguang L; Jiansheng L
    Front Pharmacol; 2024; 15():1302950. PubMed ID: 38344179
    [No Abstract]   [Full Text] [Related]  

  • 8. General practitioner use of a C-reactive protein point-of-care test to help target antibiotic prescribing in patients with acute exacerbations of chronic obstructive pulmonary disease (the PACE study): study protocol for a randomised controlled trial.
    Bates J; Francis NA; White P; Gillespie D; Thomas-Jones E; Breen R; Kirby N; Hood K; Gal M; Phillips R; Naik G; Cals J; Llor C; Melbye H; Wootton M; Riga E; Cochrane A; Howe R; Fitzsimmons D; Sewell B; Alam MF; Butler CC
    Trials; 2017 Sep; 18(1):442. PubMed ID: 28969667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Significance of Procalcitonin, C-Reactive Protein, and Interleukin-6 in Helping Guide the Antibiotic Use for Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
    Song W; Wang Y; Tian F; Ge L; Shang X; Zeng Q; Feng N; Fan J; Wang J; Ma X
    Dis Markers; 2021; 2021():8879401. PubMed ID: 33791046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation among the levels of C-reactive protein and interleukin-18, quality of life, and lung function in patients with chronic obstructive pulmonary disease].
    Long H; Luo H; Chen P; Li Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1090-6. PubMed ID: 22169727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-reactive protein levels predict bacterial exacerbation in patients with chronic obstructive pulmonary disease.
    Peng C; Tian C; Zhang Y; Yang X; Feng Y; Fan H
    Am J Med Sci; 2013 Mar; 345(3):190-4. PubMed ID: 23221507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of the Serum KL-6 with Severity and Prognosis in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Wang Y; Fei J; Xu J; Cheng ZY; Ma YC; Wu JH; Yang J; Zhao H; Fu L
    Lung; 2024 Jun; 202(3):245-255. PubMed ID: 38743087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of IGFBP7 are elevated during acute exacerbation in COPD patients.
    Ruan W; Wu M; Shi L; Li F; Dong L; Qiu Y; Wu X; Ying K
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1775-1780. PubMed ID: 28684903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of diagnostic values of procalcitonin, C-reactive protein and blood neutrophil/lymphocyte ratio levels in predicting bacterial infection in hospitalized patients with acute exacerbations of COPD.
    Tanrıverdi H; Örnek T; Erboy F; Altınsoy B; Uygur F; Atalay F; Tor MM
    Wien Klin Wochenschr; 2015 Oct; 127(19-20):756-63. PubMed ID: 25586444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between serum bilirubin, blood uric acid, and C-reactive protein and the severity of chronic obstructive pulmonary disease.
    Zhao T; Lv T
    J Health Popul Nutr; 2024 Jul; 43(1):105. PubMed ID: 38978143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotyping COPD exacerbations using imaging and blood-based biomarkers.
    Alotaibi NM; Chen V; Hollander Z; Hague CJ; Murphy DT; Leipsic JA; DeMarco ML; FitzGerald JM; McManus BM; Ng RT; Sin DD
    Int J Chron Obstruct Pulmon Dis; 2018; 13():217-229. PubMed ID: 29386890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlations between serum amyloid A, C-reactive protein and clinical indices of patients with acutely exacerbated chronic obstructive pulmonary disease.
    Lin TL; Chen WW; Ding ZR; Wei SC; Huang ML; Li CH
    J Clin Lab Anal; 2019 May; 33(4):e22831. PubMed ID: 30666727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High sensitive C-reactive protein for prediction of adverse outcome in acute exacerbation of chronic obstructive pulmonary disease.
    Tofan F; Rahimi-Rad MH; Rasmi Y; Rahimirad S
    Pneumologia; 2012; 61(3):160-2. PubMed ID: 23175870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and Prognostic Value of Inflammatory Parameters Including Neopterin in the Setting of Pneumonia, COPD, and Acute Exacerbations.
    Pizzini A; Lunger F; Sahanic A; Nemati N; Fuchs D; Weiss G; Kurz K; Bellmann-Weiler R
    COPD; 2017 Jun; 14(3):298-303. PubMed ID: 28548632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Glycerophospholipid Profile in Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Gai X; Guo C; Zhang L; Zhang L; Abulikemu M; Wang J; Zhou Q; Chen Y; Sun Y; Chang C
    Front Physiol; 2021; 12():646010. PubMed ID: 33658945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.